| Curis,
Inc. will be formed by leveraging the combined strengths
of Creative BioMolecules, Ontogeny and Reprogenesis to create
the regenerative medicine company of the future. Curis will
combine a powerful functional genomics and developmental biology
discovery engine with a robust pipeline of near-term commercial,
late-stage clinical and earlier stage developmental opportunities. |
|
 |
|
|
|
|
